You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

[18F] fluorothymidine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)

Active, not recruiting
  • Breast Neoplasm
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Aug 16, 2022

Graft Vs Host Disease Trial in Chapel Hill (Fluorothymidine (FLT))

Active, not recruiting
  • Graft Vs Host Disease
  • Fluorothymidine (FLT)
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Mar 21, 2022

Advanced Cancers Trial in Houston (PET Scan, FLT)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

Recruiting
  • Brain and Central Nervous System Tumors
  • +8 more
  • 3'-deoxy-3'-[18F]fluorothymidine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 30, 2022

Ewing Sarcoma Trial in United States (drug, diagnostic test, other)

Recruiting
  • Ewing Sarcoma
  • Trabectedin 1 MG [Yondelis]
  • +3 more
  • Los Angeles, California
  • +5 more
Aug 15, 2022

Malignant Tumor Trial in Salt Lake City ([F-18]fluorodeoxyglucose, [F-18]fluorothymidine, Positron Emission Tomography)

Terminated
Has Results
  • Malignant Neoplasm
  • [F-18]fluorodeoxyglucose
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 20, 2021

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)

Recruiting
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Response to Immune Checkpoint Blockade in Metastatic Melanoma

Completed
  • Melanoma
  • F-FDG PET/CT
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jul 7, 2022

Brain Tumors Trial in Boston ([18F] FLT)

Active, not recruiting
  • Brain Neoplasms
  • [18F] FLT
  • Boston, Massachusetts
    Children's Hospital, Boston
Aug 15, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Duarte (procedure, drug, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Biospecimen Collection
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Nov 15, 2021

Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 10, 2022

Tumors of the CNS Trial in Boston (18F-FLT, PET Imaging)

Terminated
  • Tumors of the Central Nervous System
  • Boston, Massachusetts
    Children's Hospital Boston
Oct 12, 2021

Cervical Cancer, Uterine Cancer, Vaginal Cancer Trial in Boston (Image-guided brachytherapy, 3'-Deoxy-3'-18f-Fluorothymidine)

Completed
Has Results
  • Cervical Cancer
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 8, 2022

Lymphoma Trial run by the NCI (procedure, diagnostic test, other)

Terminated
Has Results
  • Lymphoma
  • Biopsy
  • +4 more
  • Bethesda, Maryland
  • +1 more
Feb 18, 2021

[18F] Flourothymidine PET/CT Imaging for Gynecologic Cancers

Completed
Has Results
  • Gynecologic Cancer
  • [18F]Fluorothymidine (FLT) PET/CT Imaging
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 5, 2021

Cancer, Brain Tumors Trial in Salt Lake City (FLT-PET Imaging)

Completed
Has Results
  • Cancer
  • Brain Tumors
  • FLT-PET Imaging
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 20, 2021

NSCLC, Starting Pemetrexed Based Therapy, Unresectable Cancer Trial in Philadelphia (Baseline 18F-thymidine (FLT) PET/CT,

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • +2 more
  • Baseline 18F-thymidine (FLT) PET/CT
  • +2 more
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
May 11, 2021

Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

Unknown status
  • Essential Thrombocythemia
  • +2 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Sep 27, 2020

Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

Terminated
  • Essential Thrombocythemia
  • +3 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Aug 10, 2020

FLT-PET/MRI for Early Response Monitoring to Novel Cancer

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • fluorine F 18 fluorothymidine
  • +2 more
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Sep 17, 2020

Stage II Adult Soft Tissue Sarcoma, Stage IIA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma Trial (drug, other,

Withdrawn
  • Stage II Adult Soft Tissue Sarcoma
  • +5 more
  • Fluorothymidine F-18
  • +2 more
  • (no location specified)
Jun 4, 2020

Metastatic Breast Cancer Trial (18F-fluorothymidine)

Completed
  • Metastatic Breast Cancer
  • 18F-fluorothymidine
  • (no location specified)
Jun 1, 2020

Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia Trial in Washington, Bethesda, Oklahoma City

Completed
Has Results
  • Myelodysplastic Syndrome
  • +4 more
  • First Allogeneic Bone Marrow Transplant (BMT)
  • +9 more
  • Washington, District of Columbia
  • +2 more
Mar 16, 2021

Metastatic Malignant Tumor in the Brain, Primary Brain Tumor, Recurrent Brain Tumor Trial in Seattle (Computed Tomography,

Completed
Has Results
  • Metastatic Malignant Neoplasm in the Brain
  • +2 more
  • Computed Tomography
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 8, 2020

Melanoma of Unknown Primary, Metastatic Malignant Tumor in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Melanoma of Unknown Primary
  • +5 more
  • (no location specified)
Feb 13, 2020